Serial Number | 88787581 |
Word Mark | LAMP |
Filing Date | Thursday, February 6, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, May 29, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 3, 2020 |
Goods and Services | therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 |
Goods and Services | providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 |
Goods and Services | scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research and medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19 |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 10, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 10, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, February 10, 2020 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | CytoDyn Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Vancouver, WA 98660 |
Party Name | CytoDyn Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Vancouver, WA 98660 |
Event Date | Event Description |
Tuesday, May 30, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, May 29, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
Saturday, October 29, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Thursday, October 27, 2022 | SOU EXTENSION 3 GRANTED |
Thursday, October 27, 2022 | SOU EXTENSION 3 FILED |
Thursday, October 27, 2022 | SOU TEAS EXTENSION RECEIVED |
Friday, April 29, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, April 27, 2022 | SOU EXTENSION 2 GRANTED |
Wednesday, April 27, 2022 | SOU EXTENSION 2 FILED |
Wednesday, April 27, 2022 | SOU TEAS EXTENSION RECEIVED |
Wednesday, October 27, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, October 25, 2021 | SOU EXTENSION 1 GRANTED |
Monday, October 25, 2021 | SOU EXTENSION 1 FILED |
Monday, October 25, 2021 | SOU TEAS EXTENSION RECEIVED |
Tuesday, April 27, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Sunday, March 14, 2021 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
Tuesday, December 1, 2020 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Tuesday, November 3, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 3, 2020 | PUBLISHED FOR OPPOSITION |
Wednesday, October 14, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 29, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, September 29, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, September 28, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, September 28, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, March 28, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, March 28, 2020 | NON-FINAL ACTION E-MAILED |
Saturday, March 28, 2020 | NON-FINAL ACTION WRITTEN |
Saturday, March 28, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, March 28, 2020 | NON-FINAL ACTION E-MAILED |
Saturday, March 28, 2020 | NON-FINAL ACTION WRITTEN |
Thursday, March 26, 2020 | ASSIGNED TO EXAMINER |
Monday, February 10, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, February 10, 2020 | NEW APPLICATION ENTERED |